Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: J Surg Oncol. 2020 Oct 30;123(2):407–415. doi: 10.1002/jso.26282

Table 4.

Covariate balance in unmatched and propensity score-matched cohorts

Unmatched Cohort
(n=207)
Propensity Score-Matched Cohort (n=64)

No Surgery ASM p-value No Surgery ASM p-value
Age, years 61.2±8.5 55.2±9.4 0.002 59.1±7.0 57.8±5.8 0.520
CCI 1.5±2.1 1.2±1.2 0.571 0.96±1.5 1.1±1.2 0.283
MELD Score 13.5±6.7 10.3±3.4 0.030 11.4±4.9 10.7±3.4 0.621
Tumor Size, cm 9.6±10.7 6.2 ±4.4 0.153 7.7±5.3 6.2±4.7 0.335
Any Liver Directed Therapy 33.3% 52.4% 0.083 58.7% 61.1% 0.862
Receipt of Chemotherapy 36.6% 33.3% 0.770 37.0% 38.9% 0.890

CCI= Charlson Comorbidity Index, MELD=Model of End Organ Dysfunction